Phase II trial to assess the biochemical efficacy of transgenic alpha(1)-anti-trypsin as an effective treatment of cystic fibrosis

Autoria(s): Martin, Lorraine; Downey, D.; Elborn, Joseph; Bilton, D.; Keogan, M.; Edgar, J.
Data(s)

01/12/1999
Identificador

http://pure.qub.ac.uk/portal/en/publications/phase-ii-trial-to-assess-the-biochemical-efficacy-of-transgenic-alpha1antitrypsin-as-an-effective-treatment-of-cystic-fibrosis(aad1a6ab-3542-48a6-8400-8204d0b9f6cf).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Martin , L , Downey , D , Elborn , J , Bilton , D , Keogan , M & Edgar , J 1999 , ' Phase II trial to assess the biochemical efficacy of transgenic alpha(1)-anti-trypsin as an effective treatment of cystic fibrosis ' Paper presented at Winter meeting of the British Thoracic Society , London , United Kingdom , 08/12/1999 - 11/12/1999 , pp. A3-A3 .
Tipo

conferenceObject
Acesso ao item digital